P/E Ratio (TTM)
-22.83
Financial Fundamentals
DRUG • Quarterly Data • 5Y View
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2019-12-31 | -394.37 |
| 2020-03-31 | -2016.51 |
| 2020-06-30 | -308.00 |
| 2020-09-30 | -32.39 |
| 2020-12-31 | -16.44 |
| 2021-03-31 | -6.03 |
| 2021-06-30 | -4.54 |
| 2021-09-30 | -9.34 |
| 2021-12-31 | -2.49 |
| 2022-03-31 | -1.22 |
| 2022-06-30 | -1.12 |
| 2022-09-30 | -2.17 |
| 2022-12-31 | -1.93 |
| 2023-03-31 | -1.34 |
| 2023-06-30 | -2.56 |
| 2023-09-30 | -1.31 |
| 2023-12-31 | -1.20 |
| 2024-03-31 | -2.85 |
| 2024-06-30 | 6.70 |
| 2024-09-30 | -2.16 |
| 2024-12-31 | 1612.50 |
| 2025-03-31 | -31.05 |
| 2025-06-30 | -12.19 |
| 2025-09-30 | -37.01 |
| 2025-12-31 | -28.46 |
| 2026-03-31 | -22.83 |
* P/E ratios are calculated using trailing twelve-month (TTM) earnings.